Low salivary resolvin D1 to leukotriene B: A novel biomarker of non-resolving vascular inflammation4: A novel biomarker of non-resolving vascular inflammation ratio predicts carotid intima media thickness: A novel biomarker of non-resolving vascular inflammation

    loading  Checking for direct PDF access through Ovid

Abstract

Background

Different lipid mediators may have opposing effects on vascular inflammation. For example, whereas leukotriene B4 (LTB4) transduces inflammation, resolvin D1 (RvD1), which is synthesized from the omega-3 fatty acid docosahexaenoic acid, facilitates the resolution of inflammation. The aim of this study was to determine the association of the RvD1/LTB4 ratio with subclinical atherosclerosis.

Methods

Saliva samples and ultrasound measurements of the intima media thickness of the carotid artery was obtained for 254 participants. The lipid mediators RvD1 and LTB4 were measured by enzyme-linked immunosorbent assay.

Results

Participants with a salivary RvD1/LTB4 ratio >1 had a significantly lower intima media thickness than those in whom LTB4 prevailed. The salivary RvD1/LTB4 ratio independently predicted carotid intima media thickness.

Conclusions

The ratio between the proresolving and proinflammatory salivary lipid mediators RvD1 and LTB4 may serve as a biomarker of non-resolving inflammation and its relation to intima media thickness in cardiovascular disease.

Related Topics

    loading  Loading Related Articles